UK markets closed
NIKKEI 225
38,179.46 -49.65 (-0.13%) HANG SENG
19,115.06 +151.38 (+0.80%) CRUDE OIL
78.74 +0.48 (+0.61%) GOLD FUTURES
2,340.90 -34.10 (-1.44%) DOW
39,452.50 -60.34 (-0.15%) Bitcoin GBP
50,044.10 +1,139.23 (+2.33%)
Inozyme Pharma, Inc. (INZY)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:34PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 280.82M |
| Enterprise value | 161.31M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 2.36 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.21 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.54 |
| 52-week change 3 | -30.05% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 7.7950 |
| 52-week low 3 | 2.6890 |
| 50-day moving average 3 | 5.5270 |
| 200-day moving average 3 | 4.6492 |
Share statistics
| Avg vol (3-month) 3 | 692.73k |
| Avg vol (10-day) 3 | 471.15k |
| Shares outstanding 5 | 61.86M |
| Implied shares outstanding 6 | 61.86M |
| Float 8 | 34.32M |
| % held by insiders 1 | 0.52% |
| % held by institutions 1 | 93.22% |
| Shares short (30 Apr 2024) 4 | 3.39M |
| Short ratio (30 Apr 2024) 4 | 4.11 |
| Short % of float (30 Apr 2024) 4 | 5.95% |
| Short % of shares outstanding (30 Apr 2024) 4 | 5.48% |
| Shares short (prior month 28 Mar 2024) 4 | 2.58M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -32.56% |
| Return on equity (ttm) | -69.41% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -82.21M |
| Net income avi to common (ttm) | -77.11M |
| Diluted EPS (ttm) | -1.3500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 166.15M |
| Total cash per share (mrq) | 2.69 |
| Total debt (mrq) | 46.63M |
| Total debt/equity (mrq) | 39.24% |
| Current ratio (mrq) | 14.05 |
| Book value per share (mrq) | 1.92 |
Cash flow statement
| Operating cash flow (ttm) | -77.44M |
| Levered free cash flow (ttm) | -52.53M |
© 2024 Yahoo. All rights reserved.